- Title
- Fluoropolymer Functionalization of Organ-on-Chip Platform Increases Detection Sensitivity for Cannabinoids
- Creator
- Tong, Ziqiu; Esser, Lars; Voelcker, Nicolas H.; Galettis, Peter; Rudd, David; Easton, Christopher D.; Nilghaz, Azadeh; Peng, Bo; Zhu, Douer; Thissen, Helmut; Martin, Jennifer H.
- Relation
- NHMRC.APP1135054 http://purl.org/au-research/grants/nhmrc/1135054
- Relation
- Biosensors Vol. 13, Issue 8, no. 779
- Publisher Link
- http://dx.doi.org/10.3390/bios13080779
- Publisher
- MDPI AG
- Resource Type
- journal article
- Date
- 2023
- Description
- Microfluidic technology is applied across various research areas including organ-on-chip (OOC) systems. The main material used for microfluidics is polydimethylsiloxane (PDMS), a silicone elastomer material that is biocompatible, transparent, and easy to use for OOC systems with well-defined microstructures. However, PDMS-based OOC systems can absorb hydrophobic and small molecules, making it difficult and erroneous to make quantitative analytical assessments for such compounds. In this paper, we explore the use of a synthetic fluoropolymer, poly(4,5-difluoro-2,2-bis(trifluoromethyl)-1,3-dioxole-co-tetrafluoroethylene) (Teflon™ AF 2400), with excellent “non-stick” properties to functionalize OOC systems. Cannabinoids, including cannabidiol (CBD), are classes of hydrophobic compounds with a great potential for the treatment of anxiety, depression, pain, and cancer. By using CBD as a testing compound, we examined and systematically quantified CBD absorption into PDMS by means of an LC-MS/MS analysis. In comparison to the unmodified PDMS microchannels, an increase of approximately 30× in the CBD signal was detected with the fluoropolymer surface modification after 3 h of static incubation. Under perfusion conditions, we observed an increase of nearly 15× in the CBD signals from the surface-modified microchannels than from the unmodified microchannels. Furthermore, we also demonstrated that fluoropolymer-modified microchannels are compatible for culturing hCMEC/D3 endothelial cells and for CBD perfusion experiments.
- Subject
- cannabinoids; cannabidiol; microfluidics; organ-on-chip systems; detection sensitivity; tetrafluoroethylene; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1497436
- Identifier
- uon:54352
- Identifier
- ISSN:2079-6374
- Rights
- x
- Language
- eng
- Reviewed
- Hits: 1238
- Visitors: 1234
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|